EPISODE · May 2, 2026 · 14 MIN
How Big Pharma Turned Normal Cholesterol Into a $20B Problem
from Fuel Different · host Sarah Williams
Your doctor just told you your cholesterol is "high" at 210. Time for a lifetime of pills? Not so fast. That number used to be considered perfectly normal until a few drug companies needed to sell more statins. What we cover: • How Pfizer turned Lipitor into the best-selling drug ever by moving the goalposts on "healthy" cholesterol • Why the 2013 guideline changes suddenly made 13 million more Americans "sick" overnight • The real numbers: for every 100 healthy people taking statins for 5 years, maybe 1 or 2 heart attacks get prevented • How a $20 billion industry convinced us that normal became dangerous Who this is for: Anyone who's been told they need cholesterol medication but wants to understand what those numbers actually mean. Sarah breaks down the marketing machine that turned a normal body function into a medical emergency. Spoiler alert: your great-grandmother probably had "high" cholesterol her whole life and lived to 95. Chapters: 00:00 The cholesterol con begins 02:30 How normal became "dangerous" 05:15 Lipitor's $125 billion success story 08:20 What the numbers really tell us 10:45 Questions to ask your doctor This isn't about never taking medication. It's about understanding when you actually need it versus when someone's trying to sell it to you. 🎧 If this made you question what else you've been told about "healthy" numbers, follow Fuel Different. Sarah drops episodes like this daily, and tomorrow she's covering why your blood pressure reading might be total BS. Hit follow so you don't miss it. ----------- Keywords: diet advice, intermittent fasting, nutrition facts, weight loss, nutrition advice, diet myths, liver health, medical advice Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
How Big Pharma Turned Normal Cholesterol Into a $20B Problem
No transcript for this episode yet
Similar Episodes
Jan 25, 2022 ·38m
Jan 18, 2022 ·39m
Jan 11, 2022 ·37m
Jan 4, 2022 ·36m
Dec 28, 2021 ·33m
Dec 21, 2021 ·30m